Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

EYLEA 114,3 MG/ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/EYLEA 114,3 MG/ML SOLUCION INYECTABLE

Approved

STANDARD

EYLEA 114,3 MG/ML SOLUCION INYECTABLE

Bayer Ag🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jan 9, 2024
Approval ID: b8aa2ab145555879
Company: Bayer Ag
Type: Standard

Approval Details

Approval Id: b8aa2ab145555879
Drug Cima Aemps Name: EYLEA 114,3 MG/ML SOLUCION INYECTABLE
Register Number: 112797003
Holder Company Name: Bayer Ag
Marketing Company Name: Bayer Hispania S.L.
Holder Company Detail Path: /organization/bayer-ag
Authorization Date: 2024-01-09
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 114,3 mg/ml
Route Of Administration: VÍA INTRAVÍTREA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Bayer Ag
Company Detail Path: /organization/bayer-ag

Company Information

Pharmaceutical Company Name: BAYER AG
Name En: Bayer AG
Country Name: Germany
City Name: Leverkusen
Address: Leverkusen, North Rhine-Westphalia, Germany
Website: https://www.bayer.com

Active Ingredients

AFLIBERCEPT

114,3 mg/ml

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jan 9, 2024

Approval ID

b8aa2ab145555879

Type

Standard

Back to CIMA-AEMPS Approvals